NCT01004315
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
- Locations
-
- Japan Hokkaido,Tohoku,Kanto,Chubu,Kansai,Shikoku,Kyushu, Japan
Clinical trial condition
Overactive Bladder
Explore clinical trials studying Overactive Bladder. Study availability and eligibility vary by location and protocol.
363 public trials
26 recruiting studies
Overactive Bladder trial results
NCT01047046
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- UCI Women's Healthcare Orange, California, United States
NCT00431041
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +13 more
- Locations
-
- Calgary, Alberta, Canada
- Edmonton, Alberta, Canada
- Vancouver, British Columbia, Canada
- Victoria, British Columbia, Canada
NCT00350636
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +12 more
- Locations
-
- Birmingham, Alabama, United States
- Homewood, Alabama, United States
- Mobile, Alabama, United States
- Montgomery, Alabama, United States
NCT00786448
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Many Locations, Germany
NCT00775281
- Conditions
- Chronic Pelvic Pain Syndrome, Cystitis, Cystitis, Interstitial, +13 more
- Locations
-
- Dept. of Urology, Bern University Hospital Bern, Switzerland
NCT00746681
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Pfizer Investigational Site Hradec Králové, Czechia
- Pfizer Investigational Site Prague, Czechia
- Pfizer Investigational Site Prague, Czechia
- Pfizer Investigational Site Praha 4 - Krc, Czechia
Completed
Fesoterodine Flexible Dose Study
NCT00536484
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Chandler, Arizona, United States
- Pfizer Investigational Site Peoria, Arizona, United States
- Pfizer Investigational Site Tucson, Arizona, United States
NCT00883818
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Female Urogenital Diseases, +15 more
- Locations
-
- Inha University College of Medicine Inchon, South Korea
- Kangnam St. Mary's Hospital, The Catholic University of Korea Seoul, South Korea
- Asan Medical Center, Ulsan College of Medicine Seoul, South Korea
Completed
Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms
NCT00343486
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +9 more
- Locations
-
- GSK Investigational Site Av Córdoba 2424, Buenos Aires, Argentina
- GSK Investigational Site Bahía Blanca, Buenos Aires, Argentina
- GSK Investigational Site Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- GSK Investigational Site Ciudad de Buenos Aires, Buenos Aires, Argentina